Axa lessened its stake in shares of Monsanto Company (NYSE:MON) by 37.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 168,729 shares of the basic materials company’s stock after selling 100,887 shares during the period. Axa’s holdings in Monsanto were worth $19,971,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in Monsanto by 2,390.1% in the 1st quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after buying an additional 25,140,936 shares during the period. State Street Corp raised its holdings in Monsanto by 1.2% in the 1st quarter. State Street Corp now owns 20,153,966 shares of the basic materials company’s stock valued at $2,281,433,000 after buying an additional 234,582 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Monsanto by 3.6% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock valued at $1,618,703,000 after buying an additional 499,639 shares during the period. Flossbach Von Storch AG raised its holdings in Monsanto by 7.5% in the 2nd quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock valued at $520,429,000 after buying an additional 307,600 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Monsanto by 7.7% in the 1st quarter. Geode Capital Management LLC now owns 4,125,879 shares of the basic materials company’s stock valued at $466,359,000 after buying an additional 295,452 shares during the period. Institutional investors and hedge funds own 74.79% of the company’s stock.

Several analysts recently issued reports on MON shares. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a report on Friday, June 16th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a report on Wednesday, July 12th. UBS AG lowered shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price objective on the stock. in a report on Friday, August 18th. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and set a $128.00 price target (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Ten equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $124.09.

Monsanto Company (NYSE MON) opened at 118.27 on Friday. The stock’s 50 day moving average price is $117.25 and its 200-day moving average price is $116.44. The firm has a market capitalization of $51.96 billion, a P/E ratio of 25.54 and a beta of 1.07. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company’s revenue was up 1.0% on a year-over-year basis. During the same period last year, the business posted $2.17 EPS. On average, analysts forecast that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.83%. Monsanto’s payout ratio is currently 46.75%.

In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Company insiders own 0.79% of the company’s stock.

WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/17/axa-has-19-97-million-stake-in-monsanto-company-mon.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.